Financial Performance - Revenue for the six months ended June 30, 2024, reached RMB 9,407,081 thousand, a significant increase from RMB 7,504,846 thousand in the same period of 2023[3] - Profit before tax for the six months ended June 30, 2024, was RMB 1,791,714 thousand, compared to a loss of RMB 2,352,631 thousand in the same period of 2023[3] - Net profit attributable to equity shareholders of the company for the six months ended June 30, 2024, was RMB 1,766,453 thousand, a substantial improvement from a loss of RMB 2,181,210 thousand in the same period of 2023[3] - Basic and diluted earnings per share for the six months ended June 30, 2024, were RMB 4.54, compared to a loss per share of RMB 6.03 in the same period of 2023[3] - The company's profit before fair value adjustment of biological assets for the six months ended June 30, 2024, was RMB 363,125 thousand, compared to a loss of RMB 1,117,560 thousand in the same period of 2023[3] - The company achieved a net profit of RMB 1,791 million in the first half of 2024 after biological asset fair value adjustment, compared to a net loss of RMB 2,353 million in the same period of 2023[16] - Adjusted net profit for the first half of 2024 was RMB 363.125 million, compared to a loss of RMB 1,117.56 million in the same period of 2023[25] - EBITDA for the first half of 2024 was RMB 2,461.831 million, a significant improvement from a loss of RMB 1,712.708 million in the first half of 2023[25] - Revenue for the six months ended June 30, 2024, increased to RMB 9,407,081 thousand, up from RMB 7,504,846 thousand in the same period in 2023, reflecting a growth of approximately 25.4%[60] - Gross profit for the period was RMB 1,165,948 thousand, a significant improvement from a gross loss of RMB 387,606 thousand in 2023[60] - Operating profit for the six months ended June 30, 2024, was RMB 2,015,268 thousand, compared to an operating loss of RMB 2,126,152 thousand in the same period in 2023[60] - Net profit attributable to equity shareholders of the company was RMB 1,766,453 thousand, a substantial recovery from a net loss of RMB 2,181,210 thousand in 2023[60] - Earnings per share for the six months ended June 30, 2024, were RMB 4.54, a significant improvement from a loss per share of RMB 6.03 in the same period in 2023[60] - The company's comprehensive pre-tax profit was RMB 1,791,714 thousand in 2024, compared to a loss of RMB 2,352,631 thousand in 2023[78] - The company reported a net profit attributable to equity shareholders of RMB 1,766,453 thousand in the first half of 2024, compared to a loss of RMB 2,181,210 thousand in the same period of 2023[85] Segment Performance - The company's pig segment revenue reached RMB 7,449 million in the first half of 2024, a year-on-year increase of 27.5%[16] - The average selling price of pigs in the first half of 2024 increased by 4.1% compared to the same period in 2023[16] - The average cost of pigs decreased by 14.4% year-on-year in the first half of 2024 due to cost management and lower feed prices[16] - The company's poultry segment saw a 7.1% increase in average selling price for chickens in the first half of 2024 compared to 2023[16] - The average cost of chickens decreased by 11.9% year-on-year in the first half of 2024[16] - The poultry segment revenue for the first half of 2024 was RMB 1,543 million, a year-on-year increase of 0.9%, driven by a 7.1% increase in average selling price and an 11.9% decrease in average cost[19] - The auxiliary products segment revenue surged 211.5% year-on-year to RMB 414 million in the first half of 2024, primarily due to the launch of fresh meat business[20] - Total revenue for the first half of 2024 increased by 25.3% year-on-year to RMB 9,407 million, mainly driven by growth in the swine segment[20] - Revenue from sales of pigs and related products increased to RMB 7,449,257 thousand in 2024, up from RMB 5,842,287 thousand in 2023, representing a growth of 27.5%[72] - Revenue from sales of poultry and related products slightly increased to RMB 1,543,403 thousand in 2024 from RMB 1,529,529 thousand in 2023, a growth of 0.9%[72] - Revenue from sales of auxiliary products surged to RMB 414,421 thousand in 2024 from RMB 133,030 thousand in 2023, a significant increase of 211.5%[72] - Total external customer revenue for the company reached RMB 9,407,081 thousand in 2024, up from RMB 7,504,846 thousand in 2023, a growth of 25.3%[72] - The company's reportable segment profit for pig sales was RMB 1,023,486 thousand in 2024, compared to a loss of RMB 303,746 thousand in 2023[77] - The company's reportable segment profit for poultry sales was RMB 192,100 thousand in 2024, compared to a loss of RMB 88,529 thousand in 2023[77] - The company's reportable segment profit for auxiliary products was RMB 137,083 thousand in 2024, up from RMB 95,166 thousand in 2023[77] - Total reportable segment profit for the company was RMB 1,352,669 thousand in 2024, compared to a loss of RMB 297,109 thousand in 2023[77] Cost and Margin Analysis - Gross margin improved significantly from -5.2% in the first half of 2023 to 12.4% in the first half of 2024, attributed to higher swine and poultry prices and reduced costs[21] - The average cost of pigs decreased by 14.4% year-on-year in the first half of 2024 due to cost management and lower feed prices[16] - The average cost of chickens decreased by 11.9% year-on-year in the first half of 2024[16] - Financial costs decreased to RMB 223,155 thousand in the first half of 2024, down from RMB 226,479 thousand in the same period of 2023[81] - Employee costs rose to RMB 675,938 thousand in the first half of 2024, up from RMB 542,875 thousand in the same period of 2023[82] - Depreciation expenses for owned property, plant, and equipment increased to RMB 284,000 thousand in the first half of 2024, compared to RMB 246,088 thousand in the same period of 2023[83] - R&D expenses slightly decreased to RMB 111,760 thousand in the first half of 2024, down from RMB 114,944 thousand in the same period of 2023[83] Cash Flow and Liquidity - Cash and cash equivalents increased to RMB 3,490 million as of June 30, 2024, up from RMB 2,545 million at the end of 2023[24] - The company's current ratio improved to 1.0 as of June 30, 2024, compared to 0.8 at the end of 2023[24] - Net cash generated from operating activities in the first half of 2024 was RMB 1,513 million, compared to RMB 32 million in the same period of 2023[26] - Operating cash flow for the six months ended June 30, 2024, was RMB 1,512,675 thousand, a significant increase from RMB 31,830 thousand in the same period in 2023[67] - Net cash used in investing activities for the six months ended June 30, 2024, was RMB 260,462 thousand, slightly higher than RMB 256,291 thousand in the same period in 2023[67] - Net cash used in financing activities for the six months ended June 30, 2024, was RMB 314,918 thousand, compared to RMB 173,043 thousand in the same period in 2023[67] - Cash and cash equivalents increased by RMB 937,295 thousand to RMB 3,489,545 thousand as of June 30, 2024[67] - The company's cash and cash equivalents increased to RMB 3,489,545 thousand as of June 30, 2024, up from RMB 2,544,830 thousand as of December 31, 2023[62] - Cash and cash equivalents increased to RMB 4,065,712 thousand as of June 30, 2024, from RMB 3,044,625 thousand as of December 31, 2023[97] Debt and Capital Structure - Total bank loans and other borrowings as of June 30, 2024, were RMB 6,399 million, with interest rates ranging from 2.55% to 5.70%[27] - Net debt to equity ratio decreased to 102.1% as of June 30, 2024, from 156.5% as of December 31, 2023[27] - Capital expenditures for the first half of 2024 were RMB 259 million, a decrease from RMB 529 million in the same period of 2023[31] - The net interest-bearing debt to net assets ratio decreased to 163.9% as of June 30, 2024, from 338.9% as of June 30, 2023[29] - Interest-bearing borrowings increased to RMB 6,399,371 thousand as of June 30, 2024, from RMB 6,099,089 thousand as of December 31, 2023[101] - Lease liabilities increased to RMB 2,859,249 thousand as of June 30, 2024, from RMB 2,478,557 thousand as of December 31, 2023[102] Biological Assets and Fair Value Adjustments - The fair value of biological assets as of June 30, 2024, was RMB 6,631 million, up from RMB 4,923 million as of December 31, 2023[33] - The net impact of biological asset fair value adjustments on profit for the first half of 2024 was a gain of RMB 1,428 million, compared to a loss of RMB 1,235 million in the same period of 2023[33] - The total value of biological assets increased to RMB 6,630,839 thousand as of June 30, 2024, up from RMB 4,922,869 thousand at the beginning of the year[87] - The fair value of biological assets increased by RMB 655,882,000 if market prices and replacement costs rose by 10% as of June 30, 2024[92] - The fair value of biological assets decreased by RMB 668,619,000 if market prices and replacement costs fell by 10% as of June 30, 2024[92] Market and Industry Trends - China's pig slaughter volume in the first half of 2024 was 363.95 million heads, a year-on-year decrease of 3.1%[14] - China's pork production in the first half of 2024 was 29.81 million tons, a year-on-year decrease of 1.7%[14] - The average pig price in China rose to RMB 18.36 per kilogram at the end of June 2024, a 25.0% increase from the end of 2023[14] - China's breeding sow inventory at the end of June 2024 was 40.38 million heads, a year-on-year decrease of 6.0%[14] - The company's operating performance is significantly affected by the cyclical fluctuations in the prices of pigs and poultry products, as well as the prices of feed and raw materials[40] Corporate Governance and Shareholder Information - The company has adopted the principles and code provisions of the Corporate Governance Code as the benchmark for its corporate governance practices[43] - The company submitted an application to the China Securities Regulatory Commission (CSRC) on December 25, 2023, to convert certain domestic shares into H-shares, and received the filing notice on January 17, 2024, approving the conversion of up to 61,944,501 domestic shares (approximately 15.93% of the total issued share capital) into H-shares[44] - On January 22, 2024, the Hong Kong Stock Exchange approved the listing and trading of 61,944,501 H-shares, and the conversion was completed on January 30, 2024, with the shares commencing trading on January 31, 2024[44] - As of June 30, 2024, Mr. Wang Degen, a director, held 11,915,198 domestic shares (4.57% of total shares) and 11,666,269 H-shares (9.11% of H-shares) as a beneficial owner, and controlled 119,400,900 domestic shares (45.78% of total shares) through controlled entities[45] - Mr. Wang Dehui, another director, held 5,957,599 domestic shares (2.28% of total shares) and 5,596,243 H-shares (4.37% of H-shares) as a beneficial owner, and controlled 5,596,242 domestic shares (2.15% of total shares) through controlled entities[45] - Mr. Yao Hailong, a director, held 2,978,799 domestic shares (1.14% of total shares) and 977,879 H-shares (0.76% of H-shares) as a beneficial owner, and held 977,879 domestic shares (0.37% of total shares) through an employee持股平台[45] - Mr. Hu Wei, a director, held 8,936,398 domestic shares (3.43% of total shares) as a beneficial owner[45] - As of June 30, 2024, the total issued share capital of the company was 388,875,636 shares[45] - On January 30, 2024, 4,734,536 domestic shares and 861,707 domestic shares held by employee持股平台众诚金宜 and同创德恒, respectively, were converted into H-shares as part of the H-share全流通 process[46] - The company disclosed that no other significant post-reporting period events occurred as of the date of the interim report[44] - Desheng Ronghe holds 119,400,900 domestic shares, representing 45.78% of the relevant shares and 30.70% of the total share capital[48] - Zhang Qiang holds 131,316,098 domestic shares, representing 50.35% of the relevant shares and 33.77% of the total share capital[48] - Chen Yuxin holds 44,681,989 H-shares, representing 34.89% of the relevant shares and 11.49% of the total share capital[48] - Guangkong Mailang holds 37,570,873 domestic shares, representing 14.41% of the relevant shares and 9.66% of the total share capital[48] - Guangkong Huiling Investment (Shanghai) Co., Ltd. holds 40,277,640 domestic shares, representing 15.44% of the relevant shares and 10.36% of the total share capital[48] - Everbright Shenzhen holds 52,556,983 domestic shares, representing 20.15% of the relevant shares and 13.52% of the total share capital[48] - China Everbright Limited holds 52,556,983 domestic shares, representing 20.15% of the relevant shares and 13.52% of the total share capital[48] - Honorich Holdings Limited holds 52,556,983 domestic shares, representing 20.15% of the relevant shares and 13.52% of the total share capital[48] - China Everbright Group holds 52,556,983 domestic shares, representing 20.15% of the relevant shares and 13.52% of the total share capital[48] - Central Huijin Investment holds 52,556,983 domestic shares, representing 20.15% of the relevant shares and 13.52% of the total share capital[48] Fund Utilization and Capital Commitments - Global offering net proceeds amounted to HKD 952.5 million, with HKD 601.9 million (63.2%) utilized as of June 30, 2024, leaving HKD 350.6 million unused[54] - Funds allocated for expanding existing pig and yellow-feathered broiler farming: HKD 476.3 million, with HKD 381 million utilized and HKD 95.3 million remaining[54] - Funds allocated for food processing business development: HKD 142.9 million, with HKD 56.6 million utilized and HKD 86.3 million remaining[54] - Funds allocated for R&D and IT systems: HKD 95.3 million, with HKD 50.7 million utilized and HKD 44.6 million remaining[54] - Funds allocated for strategic investments or potential acquisitions: HKD 95.3 million, with none utilized as of June 30, 2024[54] - Funds allocated for repayment of bank loans: HKD 47.6 million, fully utilized[54] - Funds allocated for working capital and general corporate purposes: HKD 95.1 million, with HKD 66 million utilized and HKD 29.1 million remaining[54] - Total capital commitments as of June 30, 2024, were RMB 467 million, up from RMB 308 million as of December 31, 2023[32] - Unprovided capital commitments increased by RMB 158,375 thousand to RMB 466,741 thousand as of June
德康农牧(02419) - 2024 - 中期财报